Function of the transcriptional regulating protein of 132 kDa (TReP-132) on human P450scc gene expression

Endocrine Research

Volumn 28, Issue 4, 2002, Pages 559-574

  Gizard, Florence ^a,c   El Alfy, Mohamed ^a,c   Duguay, Yannick ^a,c   Lavallée, Bernard ^a,c   DeWitte, Fredérique ^a,c   Staels, Bart ^b,c   Beatty, Barbara G ^c,d   Hum, Dean W ^a,c,e  

^a UNIVERSITÉ LAVAL   (Canada)

^b INSTITUT PASTEUR DE LILLE   (France)

^c Cancer Center Ontario   (Canada)

^d UNIVERSITY OF VERMONT   (United States)

^e Parc Eurasante Lille Metropole   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; PROTEIN; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX; CELL LINE; CLONE; CONFERENCE PAPER; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INTERACTION; STEROIDOGENESIS; TESTIS; TRANSCRIPTION REGULATION;

CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATE; PROTEIN ISOFORMS; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036943340     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-120016841     Document Type: Conference Paper

References (38)

1. Waterman, M.R. et al. Control of gene expression of adrenal steroid hydroxylases and related enzymes. Endocr. Res. 1986, 12 (4), 393-408.
2. Honda, S. et al. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J. Biol. Chem. 1993, 268 (10), 7494-7502.
3. Lala, D.S.; Rice, D.A.; Parker, K.L. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of Fushi tarazu-factor I. Mol. Endocrinol. 1992, 6 (8), 1249-1258.
4. Rice, D.A. et al. A shared promoter element regulates the expression of three steroidogenic enzymes. Mol. Endocrinol. 1991, 5 (10), 1552-1561.
5. Morohashi, K. et al. Function and distribution of a steroidogenic cell-specific transcription factor, Ad4BP. J. Steroid. Biochem. Mol. Biol. 1995, 53 (1-6), 81-88.
6. Monte, D.; DeWitte, F.; Hum, D.W. Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300. J. Biol. Chem. 1998, 273 (8), 4585-4591.
7. Gizard, F. et al. The transcriptional regulating protein of 132kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells. J. Biol. Chem. 2002, 5, 5.
8. Huang, N.; Miller, W.L. Cloning of factors related to HIV-Inducible LBP proteins that regulate steroidogenic factor-1-independent human placental transcription of the cholesterol side-chain cleavage enzyme, P450scc. J. Biol. Chem. 2000, 275 (4), 2852-2858.
9. Gizard, F. et al. A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression. J. Biol. Chem. 2001, 276 (36), 33881-33892.
10. Rodriguez, H. et al. Transcription of the human genes for cytochrome P450scc and P450c17 is regulated differently in human adrenal NCI-H295 cells than in mouse adrenal Y1 cells. J. Clin. Endocrinol. Metab. 1997, 82 (2), 365-371.
11. Hum, D.W.; Aza-Blanc, P.; Miller, W.L. Characterization of placental transcriptional activation of the human gene for P450scc. DNA Cell Biol. 1995, 14 (5), 451-463.
12. Jiang, W.; Beatty, B.G. Identification and localization of MEP1A-Like sequences (MEP1AL1-4) in the human genome. Biochem. Biophys. Res. Commun. 1999, 261 (1), 163-168.
13. Nature, h.g.i., Nature 2001, 409, 6822.
14. Qi, H. et al. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 That is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Cancer. Res. 2002, 62 (3), 721-733.
15. Duguay, Y. et al. Region specific expression of mTReP-132 in brain. Mol. Psychiatry. 2002, In Press.
16. Biedenkapp, H. et al. Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 1988, 335 (6193), 835-837.
17. Klempnauer, K.H.; Sippel, A.E. The highly conserved amino-terminal region of the protein encoded by the v-myb oncogene functions as a DNA-binding domain. Embo. J. 1987, 6 (9), 2719-2725.
18. Aasland, R.; Stewart, A.F.; Gibson, T. The SANT domain: A putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem. Sci. 1996, 21 (3), 87-88.
19. Pikuleva, I.; Waterman, M. Cytochromes P450 in synthesis of steroid hormones, bile acids, vitamin D3 and cholesterol. Mol. Aspects. Med. 1999, 20 (1-2), 33-42, 43-37.
20. Parker, K.L.; Schimmer, B.P. Steroidogenic factor 1: A key determinant of endocrine development and function. Endocr. Rev. 1997, 18 (3), 361-377.
21. Mitchell, P.J.; Tjian, R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989, 245 (4916), 371-378.
22. Tanaka, M.; Lai, J.S.; Herr, W. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 1992, 68 (4), 755-767.
23. Unger, T. et al. p53: A transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. Embo. J. 1992, 11 (4), 1383-1390.
24. Heery, D.M. et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997, 387 (6634), 733-736.
25. Laity, J.H.; Dyson, H.J.; Wright, P.E. Molecular basis for modulation of biological function by alternate splicing of the wilms' tumor suppressor protein. Proc. Natl. Acad. Sci. USA 2000, 97 (22), 11932-11935.
26. Rauscher, F.J., 3rd. et al. Binding of the wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 1990, 250 (4985), 1259-1262.
27. Bickmore, W.A. et al. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science 1992, 257 (5067), 235-237.
28. Nachtigal, M.W. et al. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998, 93 (3), 445-454.
29. Larsson, S.H. et al. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 1995, 81 (3), 391-401.
30. Davies, R.C. et al. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev. 1998, 12 (20), 3217-3225.
31. Mermod, N. et al. The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell 1989, 58 (4), 741-753.
32. Tanaka, M.; Clouston, W.M.; Herr, W. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription. Mol. Cell. Biol. 1994, 14 (9), 6046-6055.
33. Moore, C.C.; Hum, D.W.; Miller, W.L. Identification of positive and negative placenta-specific basal elements and a cyclic adenosine 3′,5′-monophosphate response element in the human gene for P450scc. Mol. Endocrinol. 1992, 6 (12), 2045-2058.
34. Hu, M.C. et al. Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol. Endocrinol. 2001, 15 (5), 812-818.
35. Sadovsky, Y. et al. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. USA 1995, 92 (24), 10939-10943.
36. Ito, M.; Yu, R.; Jameson, J.L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 1997, 17 (3), 1476-1483.
37. Ramayya, M.S. et al. Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. J. Clin. Endocrinol. Metab. 1997, 82 (6), 1799-1806.
38. Wagner, S.; Green, M.R. DNA-binding domains: Targets for viral and cellular regulators. Curr. Opin. Cell. Biol. 1994, 6 (3), 410-414.